Loading...
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
BACKGROUND: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of the seriou...
Na minha lista:
Udgivet i: | Surg Case Rep |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Springer Berlin Heidelberg
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736507/ https://ncbi.nlm.nih.gov/pubmed/29260338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0399-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|